These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 19515181

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adding saxagliptin to extended-release metformin vs. uptitrating metformin dosage.
    Fonseca V, Zhu T, Karyekar C, Hirshberg B.
    Diabetes Obes Metab; 2012 Apr; 14(4):365-71. PubMed ID: 22192246
    [Abstract] [Full Text] [Related]

  • 5. Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes.
    Mathieu C, Ranetti AE, Li D, Ekholm E, Cook W, Hirshberg B, Chen H, Hansen L, Iqbal N.
    Diabetes Care; 2015 Nov; 38(11):2009-17. PubMed ID: 26246458
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double-blind, active-controlled, phase 3 trial.
    Dou J, Ma J, Liu J, Wang C, Johnsson E, Yao H, Zhao J, Pan C.
    Diabetes Obes Metab; 2018 Mar; 20(3):590-598. PubMed ID: 28926170
    [Abstract] [Full Text] [Related]

  • 9. Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetes.
    Sjöstrand M, Iqbal N, Lu J, Hirshberg B.
    Diabetes Res Clin Pract; 2014 Aug; 105(2):185-91. PubMed ID: 24947443
    [Abstract] [Full Text] [Related]

  • 10. The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone.
    DeFronzo RA, Hissa MN, Garber AJ, Luiz Gross J, Yuyan Duan R, Ravichandran S, Chen RS, Saxagliptin 014 Study Group.
    Diabetes Care; 2009 Sep; 32(9):1649-55. PubMed ID: 19478198
    [Abstract] [Full Text] [Related]

  • 11. Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes.
    Rosenstock J, Aguilar-Salinas C, Klein E, Nepal S, List J, Chen R, CV181-011 Study Investigators.
    Curr Med Res Opin; 2009 Oct; 25(10):2401-11. PubMed ID: 19650754
    [Abstract] [Full Text] [Related]

  • 12. Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy.
    Barnett AH, Charbonnel B, Li J, Donovan M, Fleming D, Iqbal N.
    Clin Drug Investig; 2013 Oct; 33(10):707-17. PubMed ID: 23949898
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.
    Göke B, Gallwitz B, Eriksson J, Hellqvist A, Gause-Nilsson I, D1680C00001 Investigators.
    Int J Clin Pract; 2010 Nov; 64(12):1619-31. PubMed ID: 20846286
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone.
    Hollander P, Li J, Allen E, Chen R, CV181-013 Investigators.
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4810-9. PubMed ID: 19864452
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus.
    Scheen AJ, Charpentier G, Ostgren CJ, Hellqvist A, Gause-Nilsson I.
    Diabetes Metab Res Rev; 2010 Oct; 26(7):540-9. PubMed ID: 20824678
    [Abstract] [Full Text] [Related]

  • 19. Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus stratified by cardiovascular disease history and cardiovascular risk factors: analysis of 3 clinical trials.
    Cook W, Minervini G, Bryzinski B, Hirshberg B.
    Postgrad Med; 2014 Oct; 126(6):19-32. PubMed ID: 25414932
    [Abstract] [Full Text] [Related]

  • 20. Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.
    Chacra AR, Tan GH, Apanovitch A, Ravichandran S, List J, Chen R, CV181-040 Investigators.
    Int J Clin Pract; 2009 Sep; 63(9):1395-406. PubMed ID: 19614786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.